VF
CLGN icon

Virtu Financial’s CollPlant Biotechnologies CLGN Stock Holding History

Virtu Financial’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7K Buy
12,600
+794
+7% +$801 ﹤0.01% 1480
2025
Q4 		$17K Buy
+11,806
New +$24.2K ﹤0.01% 1456

Other funds holding CLGN

SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LWMI
Legacy Wealth Management (Idaho) Boise, Idaho $201M AUM 259.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return

Virtu Financial's CLGN Position: Q1 2026 in Review

Virtu Financial increased its CollPlant Biotechnologies (CLGN) stake by 6.7% in Q1 2026, buying an estimated $801 and bringing the position to 12,600 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1480.

Virtu Financial first reported a position in CLGN in Q4 2025 and has held it in 2 quarters since. The position peaked at $17K in Q4 2025. 21 funds tracked by Wall St. Rank hold CLGN as of Q1 2026.

  • Virtu Financial held 12,600 shares of CollPlant Biotechnologies worth $7K as of Q1 2026.
  • Virtu Financial bought 794 CollPlant Biotechnologies shares in Q1 2026, an estimated $801.
  • CollPlant Biotechnologies made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1480 holding.
  • Virtu Financial first reported a position in CollPlant Biotechnologies in Q4 2025 and has held it in 2 quarters since.
  • Virtu Financial's CollPlant Biotechnologies position peaked at $17K in Q4 2025.
  • 21 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.